Well Differentiated Pancreatic Endocrine Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-09-09
Clinical Trial Update: Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs [Phase 2]
Phase 2 clinical trial investigating the combination of everolimus, octreotide LAR, and metformin in well-differentiated pancreatic neuroend…